Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats

Metabolism: Clinical and Experimental

Volumn 62, Issue 1, 2013, Pages 52-61

  Kannan, M Mari ^a,b   Quine, S Darlin ^c  

^a SASTRA UNIVERSITY   (India)

^b Jayamukhi College of Pharmacy   (India)

^c GOVERNMENT ARTS COLLEGE   (India)

Author keywords

Isoproterenol; Lipid profile; Necrotic score; Ventricular hypertrophy

Indexed keywords

CREATINE KINASE MB; ELLAGIC ACID; ISOPRENALINE; MYOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE NECROSIS; HEART RHYTHM; HEART VENTRICLE HYPERTROPHY; HYPERLIPIDEMIA; LIPID METABOLISM; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ELLAGIC ACID; HISTOCYTOCHEMISTRY; HYPERLIPIDEMIAS; HYPERTROPHY; MALE; MYOCARDIAL INFARCTION; MYOGLOBIN; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84870933361     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.06.003     Document Type: Article

References (46)

1. N.R. Matthan, H. Jordan, and M. Chung A systematic review and meta-analysis of the impact of ω-3 fatty acids on selected arrhythmia outcomes in animal models Metabolism 54 2005 1557 1565
2. M. Schoepe, A. Schrepper, and M. Schwarzer Exercise can induce temporary mitochondrial and contractile dysfunction linked to impaired respiratory chain complex activity Metabolism 61 2012 117 126
3. Y.B. Liu, C.C. Wu, and C.M. Lee Dyslipidemia is associated with ventricular tachyarrhythmia in patients with acute ST-segment elevation myocardial infarction J Formos Med Assoc 105 2006 17 24
4. A.A. Alsheikh-Ali, J.T. Kuvin, and R.H. Karas Risk of adverse events with fibrates Am J Cardiol 94 2004 935 938
5. Y. Amakura, M. Okada, and S. Tsuji Determination of ellagic acid in fresh and processed fruits by HPLC J Food Hyg Soc Jpn 41 2000 206 211
6. A.P. Rogerio, C. Fontanari, and E. Borducchi Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma Eur J Pharmacol 580 2008 262 270
7. C. Girish, B.C. Koner, and S. Jayanthi Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice Fundam Clin Pharmacol 23 2009 735 745
8. B.A. Narayanan, O. Geoffroy, and M.C. Willingham p53/p21 (WAF1/C1P1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells Cancer Lett 136 1999 215 221
9. M. Mari Kannan, and S. Darlin Quine Ellagic acid ameliorates isoproterenol induced oxidative stress: evidence from electrocardiological, biochemical and histological study Eur J Pharmacol 659 2011 45 52
10. L. Li, L.K. Zhang, and Y.Z. Pang Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats Acta Pharmacol Sin 27 2006 527 535
11. T. Arpad, W. Brian, and Y. Fumio Isoproterenol and the genesis of reperfusion-induced arrhythmias in isolated rat heart: adrenoceptor or free radical-mediated mechanisms? J Cardiovasc Pharmacol 15 1990 398 407
12. H. Frans, H. Leenen, and R. White Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system Am J Physiol Heart Circ Physiol 281 2001 H2410 H2416
13. D. Grimm, D. Elsner, and H. Schunkert Development of heart failure following isoproterenol administration in the rat: role of rennin angiotensin system Cardiovas Res 37 1998 91 100
14. V.R. Punithavathi, and P. Stanely Mainzen Prince Pretreatment with a combination of quercetin and α-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats Life Sci 86 2010 178 184
15. R.M. Fryer, A.K. Hsu, and H. Nagase Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels J Pharmacol Exp Ther 294 2000 451 457
16. M.J. Curtis, and M.J. Walker Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia Cardiovasc Res 22 1988 656 665
17. K.M. Johnston, B.A. MacLeod, and M.J. Walker Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics Can J Physiol Pharm 61 1983 1340 1353
18. R.C. Gupta, X.P. Yang, and S. Mishra Assessment of sarcoplasmic reticulum Ca2+-uptake during the development of left ventricular hypertrophy Biochem Pharmacol 65 2003 933 939
19. K. Yagi, Y. Shidoji, and S. Komura Dissipation of mitochondrial membrane potential by exogenous phospholipid monohydroperoxide and protection against this effect by transfection of cells with phospholipid hydroperoxide glutathione peroxidase gene Biochem Biophys Res Commun 245 1998 528 533
20. Z.Y. Jiang, J.V. Hunt, and S.P. Wolff Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein Anal Biochem 202 1992 384 389
21. J. Folch, M. Lees, and S.G.H. Sloane A simple method for isolation and purification of total lipids from animal tissues J Biol Chem 226 1957 497 509
22. K. Falholt, B. Lund, and W. Falholt An easy colorimetric micromethod for routine determination of free fatty acids in plasma Clin Chim Acta 46 1973 105 111
23. D.B. Zilversmit, and A.K. Davis Microdetermination of plasma phospholipids by trichloroacetic acid precipitation J Lab Clin Med 35 1950 155 160
24. A.V. Rao, and S. Ramakrishnan Indirect assessment of hydroxymethyl glutaryl-CoA reductase (NADPH) activity in liver tissue Clin Chem 21 1975 1523 1525
25. S. Dixit, E.P. Gerstenfeld, and D.J. Callans Mechanisms underlying sustained firing from pulmonary veins: evidence from pacing maneuvers and pharmacological manipulation Pacing Clin Electrophysiol 27 2004 1120 1129
26. Y.J. Chen, S.A. Chen, and Y.C. Chen Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation Circulation 104 2001 2849 2854
27. Y. Higuchi, K. Otsu, and K. Nishida Involvement of reactive oxygen species mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy J Mol Cell Cardiol 34 2002 233 240
28. M.E. Ritchie Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris Circulation 98 1998 1707 1713
29. S.C. Wong, M. Fukuchi, and P. Melnyk Induction of cyclooxygenase- 2 and activation of nuclear factor-kappa B in myocardium of patients with congestive heart failure Circulation 98 1998 100 103
30. M. Mari Kannan, and S. Darlin Quine Pharmacodynamics of ellagic acid on cardiac troponin-T, lyosomal enzymes and membrane bound ATPases: mechanistic clues from biochemical, cytokine and in vitro studies Chem Biol Interact 193 2011 154 161
31. J. Bock, G. Brogan, and C. McCuskey Evaluation of CK-MB isoform analysis for early diagnosis of myocardial infarction J Emerg Med 17 1999 75 79
32. R. Sriram, U. Kreutzer, and L. Shih Interaction of fatty acid with myoglobin FEBS Lett 582 2008 3643 3649
33. J. Mair, D. Morandell, and N. Genser Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction Clin Chem 41 1995 1266 1272
34. J.C. Swaanenburg, M.J. Dejongste, and M. Volmer Analytical aspects of the automated CK-MB1,2 and CKMM1,2,3 isoform determination and its relation to other biochemical markers Scand J Clin Lab Invest 58 1998 167 176
35. K. Senthil Kumaran, and P. Stanely Mainzen Prince Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study Metabolism 59 2010 1172 1180
36. A. Yüce, A. Ateşşahin, and A.O. Ceribaşi Amelioration of cyclosporine A-induced renal, hepatic and cardiac damages by ellagic acid in rats Basic Clin Pharmacol Toxicol 103 2008 186 191
37. R. Anandan, S. Mathew, and T.V. Sankar Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol induced myocardial infarction in rats Prostaglandins Leukot Essent Fatty Acids 76 2007 153 158
38. I.A. Paritha, and C.S. Devi Effect of α-tocopherol on isoproterenol-induced changes in lipids and lipoprotein profile in rats Indian J Pharmacol 29 1997 399 404
39. V.R. Punithavathi, and P. Stanely Mainzen Prince Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats Chem Biol Interact 181 2009 322 327
40. A.S. Meyer, M. Heinonen, and E.N. Frankel Antioxidant, interactions of catechin, cyanidin, caffeic acid, quercetin and ellagic acid on human LDL oxidation Food Chem 61 1998 71 75
41. Y.M. Yu, W.C. Chang, and C.S. Wu Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid J Nutr Biochem 16 2005 675 681
42. Y. Rayssiguier, and E. Gueux Magnesium and lipids in cardiovascular diseases J Am Coll Nutr 5 1986 507 519
43. A. De Curtis, S. Murzilli, and A. Di Castelnuovo Alcohol free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the 'French paradox' J Thromb Haemost 3 2005 346 350
44. P. Prince, and K. Kumaran Preventive effects of caffeic acid on lipids, lipoproteins and glycoproteins in isoproterenol induced myocardial infarcted rats Food Res Int 45 2012 155 160
45. B. Conway, R.W. Evans, and L. Fried FFAs are associated with pulse pressure may lead to cardiac arrhythmias, ischemia, and sudden cardiac death Metabolism 58 2009 1215 1221
46. J. Tamargo, R. Caballero, and R. Gómez Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy Pharmacol Ther 114 2007 107 126